These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 18720913
1. Different effects of angiogenesis inhibitors IFN-alpha and TIMP-1 on lymphangiogenesis. Shao XJ, Lu WQ, Liu C. Lymphology; 2008 Jun; 41(2):64-74. PubMed ID: 18720913 [Abstract] [Full Text] [Related]
4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY. Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341 [Abstract] [Full Text] [Related]
5. Influence of angiogenesis inhibitors, endostatin and PF-4, on lymphangiogenesis. Shao XJ, Xie FM. Lymphology; 2005 Mar 20; 38(1):1-8. PubMed ID: 15856679 [Abstract] [Full Text] [Related]
7. Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha. Sgonc R, Fuerhapter C, Boeck G, Swerlick R, Fritsch P, Sepp N. Int Arch Allergy Immunol; 1998 Nov 20; 117(3):209-14. PubMed ID: 9831809 [Abstract] [Full Text] [Related]
8. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells]. Yang F, He YL. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul 20; 26(7):978-80. PubMed ID: 16864091 [Abstract] [Full Text] [Related]
9. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization. Noguchi R, Yoshiji H, Ikenaka Y, Kitade M, Kaji K, Yoshi J, Yanase K, Namisaki T, Yamazaki M, Tsujimoto T, Akahane T, Uemura M, Fukui H. Int J Oncol; 2008 Jan 20; 32(1):193-9. PubMed ID: 18097559 [Abstract] [Full Text] [Related]
10. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis. Zania P, Gourni D, Aplin AC, Nicosia RF, Flordellis CS, Maragoudakis ME, Tsopanoglou NE. J Pharmacol Exp Ther; 2009 Feb 20; 328(2):378-89. PubMed ID: 18988770 [Abstract] [Full Text] [Related]
11. Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4. Fernández CA, Moses MA. Biochem Biophys Res Commun; 2006 Jun 23; 345(1):523-9. PubMed ID: 16682001 [Abstract] [Full Text] [Related]
12. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y. Eur J Obstet Gynecol Reprod Biol; 2008 Sep 23; 140(1):95-102. PubMed ID: 18440692 [Abstract] [Full Text] [Related]
13. The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells. Imai S, Yoshida Y, Okamura T, Nagano K, Abe Y, Yoshikawa T, Kamada H, Nakagawa S, Tsunoda S, Tsutsumi Y. Pharmazie; 2009 Mar 23; 64(3):214-6. PubMed ID: 19348346 [Abstract] [Full Text] [Related]
14. Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. Campostrini N, Marimpietri D, Totolo A, Mancone C, Fimia GM, Ponzoni M, Righetti PG. Proteomics; 2006 Aug 23; 6(15):4420-31. PubMed ID: 16888724 [Abstract] [Full Text] [Related]
15. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides]. Chen HM, Yan XJ, Wang F, Lin J, Xu WF. Yao Xue Xue Bao; 2007 Jun 23; 42(6):595-600. PubMed ID: 17702394 [Abstract] [Full Text] [Related]
16. A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Mabeta P, Pepper MS. Angiogenesis; 2009 Jun 23; 12(1):81-90. PubMed ID: 19214765 [Abstract] [Full Text] [Related]
17. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, Deepak V, Muniyandi J, Eom SH, Gurunathan S. Colloids Surf B Biointerfaces; 2009 Oct 01; 73(1):51-7. PubMed ID: 19481908 [Abstract] [Full Text] [Related]
18. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Scholz A, Wagner K, Welzel M, Remlinger F, Wiedenmann B, Siemeister G, Rosewicz S, Detjen KM. Gut; 2009 Feb 01; 58(2):261-70. PubMed ID: 18829975 [Abstract] [Full Text] [Related]
19. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. Chintalapati M, Truax R, Stout R, Portier R, Losso JN. J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359 [Abstract] [Full Text] [Related]
20. A biologically active angiogenesis inhibitor, human serum albumin-TIMP-2 fusion protein, secreted from Saccharomyces cerevisiae. Kang WK, Park EK, Lee HS, Park BY, Chang JY, Kim MY, Kang HA, Kim JY. Protein Expr Purif; 2007 Jun 24; 53(2):331-8. PubMed ID: 17368046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]